hangon
- 03 Sep 2008 15:24
This is the new face of Maelor; with emphasis on late-stage drugs - and hopefully commercialisation. This change appears to be the reason for the name-change..
"...Good luck to all who sail in her..."
Anyone?
Investinggarden
- 08 Jul 2009 12:15
- 2 of 2